Cochlear (ASX:COH) - Hisse Senedi Fiyatı, Haberler ve Analizler

COH Stoklara Genel Bakış

Cochlear Limited, dünya çapında çocuklar ve yetişkinler için implante edilebilir işitme çözümleri sunmaktadır. Daha fazla detay

COH temel anali̇z
Kar Tanesi Skoru
Değerleme	0/6
Gelecekteki Büyüme	3/6
Geçmiş Performans	3/6
Finansal Sağlık	6/6
Temettüler	0/6

Ödüller

Fiyat-Kazanç oranı ( 53.7 x) Medical Equipment endüstri ortalamasının ( 54.7 x) altındadır

Kazançların yılda 11.67% oranında artması öngörülüyor

Kazançlar son 5 yılda yılda 22.8% oranında arttı

Risk Analizi

COH risk kontrollerimizi geçti.

Cochlear Limited Rakipler

Sonic Healthcare

ASX:SHL

AU$13.3b

Ramsay Health Care

ASX:RHC

AU$8.7b

Austco Healthcare

ASX:AHC

AU$87.4m

Ansell

ASX:ANN

AU$4.7b

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Cochlear
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	AU$293.02
52 Haftanın En Yüksek Seviyesi	AU$350.31
52 Haftanın En Düşük Seviyesi	AU$258.25
Beta	0.46
11 Aylık Değişim	2.63%
3 Aylık Değişim	-4.39%
1 Yıllık Değişim	12.59%
33 Yıllık Değişim	27.88%
5 Yıllık Değişim	25.37%
Halka arzdan bu yana değişim	9,832.88%

Son Haberler & Güncellemeler

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Nov 19

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Nov 04

We Think Shareholders May Consider Being More Generous With Cochlear Limited's (ASX:COH) CEO Compensation Package

Oct 18

Cochlear Limited's (ASX:COH) Shareholders Might Be Looking For Exit

Sep 19

Recent updates

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Nov 19

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Nov 04

We Think Shareholders May Consider Being More Generous With Cochlear Limited's (ASX:COH) CEO Compensation Package

Oct 18

Cochlear Limited's (ASX:COH) Shareholders Might Be Looking For Exit

Sep 19

Cochlear Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Aug 16

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Oct 04

Cochlear (ASX:COH) Could Be Struggling To Allocate Capital

Sep 12

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Jun 05

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Apr 05

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Mar 04

Is Cochlear (ASX:COH) A Risky Investment?

Dec 19

Is Cochlear Limited (ASX:COH) Worth AU$205 Based On Its Intrinsic Value?

Nov 16

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Oct 25

Should Shareholders Reconsider Cochlear Limited's (ASX:COH) CEO Compensation Package?

Oct 11

Cochlear's (ASX:COH) Upcoming Dividend Will Be Larger Than Last Year's

Aug 28

Here's Why Cochlear (ASX:COH) Can Manage Its Debt Responsibly

Aug 23

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Jul 16

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

May 19

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Apr 09

Estimating The Intrinsic Value Of Cochlear Limited (ASX:COH)

Feb 04

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Dec 24

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Oct 30

This Is Why We Think Cochlear Limited's (ASX:COH) CEO Might Get A Pay Rise Approved By Shareholders

Oct 12

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

Oct 06

Returns On Capital Signal Tricky Times Ahead For Cochlear (ASX:COH)

Aug 16

Cochlear (ASX:COH) Has A Pretty Healthy Balance Sheet

Jun 24

A Look At The Intrinsic Value Of Cochlear Limited (ASX:COH)

May 17

Hissedar Getirileri

	COH	AU Medical Equipment	AU Pazar
7D	-0.9%	0.5%	1.5%
1Y	12.6%	14.2%	17.2%

Getiri vs. Endüstri: COH geçen yıl % 14.2 oranında getiri sağlayan Australian Medical Equipment sektörünün gerisinde kaldı.

Getiri vs Piyasa: COH geçen yıl % 17.2 oranında getiri sağlayan Australian Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is COH's price volatile compared to industry and market?
COH volatility
COH Average Weekly Movement	2.7%
Medical Equipment Industry Average Movement	9.1%
Market Average Movement	8.6%
10% most volatile stocks in AU Market	17.3%
10% least volatile stocks in AU Market	3.4%

İstikrarlı Hisse Senedi Fiyatı: COH son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: COH 'nin haftalık oynaklığı ( 3% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
1981	5,047	Dig Howitt	www.cochlear.com

Cochlear Limited, dünya çapında çocuklar ve yetişkinler için implante edilebilir işitme çözümleri sunmaktadır. Koklear implant sistemleri, ses işlemcisi yükseltmeleri, kemik iletim sistemleri, aksesuarlar ve diğer ürünler sunmaktadır. Şirket 1981 yılında kurulmuştur ve merkezi Avustralya'nın Sidney kentindedir.

Cochlear Limited Temel Bilgiler Özeti

Cochlear'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
COH temel i̇stati̇sti̇kler
Piyasa değeri	AU$19.50b
Kazançlar(TTM)	AU$356.80m
Gelir(TTM)	AU$2.24b

53.7x

F/K Oranı

8.6x

P/S Oranı

COH aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
COH gelir tablosu (TTM)
Gelir	AU$2.24b
Gelir Maliyeti	AU$562.10m
Brüt Kâr	AU$1.67b
Diğer Giderler	AU$1.32b
Kazançlar	AU$356.80m

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

Feb 13, 2025

Hisse başına kazanç (EPS)	5.45
Brüt Marj	74.86%
Net Kâr Marjı	15.96%
Borç/Özkaynak Oranı	0%

COH uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

1.4%

Mevcut Temettü Verimi

75%

Ödeme Oranı

COH Stoklara Genel Bakış

Ödüller

Risk Analizi

Cochlear Limited Rakipler

ASX:SHL

AU$13.3b

ASX:RHC

AU$8.7b

ASX:AHC

AU$87.4m

ASX:ANN

AU$4.7b

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

CEO, MD exercised options and sold AU$3.1m worth of stock

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

We Think Shareholders May Consider Being More Generous With Cochlear Limited's (ASX:COH) CEO Compensation Package

Now 20% overvalued

Cochlear Limited's (ASX:COH) Shareholders Might Be Looking For Exit

Recent updates

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

CEO, MD exercised options and sold AU$3.1m worth of stock

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

We Think Shareholders May Consider Being More Generous With Cochlear Limited's (ASX:COH) CEO Compensation Package

Now 20% overvalued

Cochlear Limited's (ASX:COH) Shareholders Might Be Looking For Exit

CEO, MD exercised options and sold AU$613k worth of stock

Stu Sayers to Appoint as President, Asia Pacific & Latin America of Cochlear Limited, Effective from 1 January 2025

Upcoming dividend of AU$2.10 per share

Final dividend of AU$2.10 announced

Cochlear Limited Announces Ordinary Dividend for the Period of Six Months Ended June 30, 2024, Payable on October 10, 2024

Cochlear Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Full year 2024 earnings: EPS misses analyst expectations

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Investors Could Be Concerned With Cochlear's (ASX:COH) Returns On Capital

Cochlear Limited Appoints Caroline Clarke as Non-Executive Director, Effective from 2 September 2024

Cochlear Limited Announces Executive Changes

Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Cochlear Limited Announces Company Secretary Changes

Cochlear Limited Receives Fda Clearance to Lower the Age for the Osia System to 5-Year-Old

Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively

Upcoming dividend of AU$2.00 per share

First half dividend increased to AU$2.00

Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

First half 2024 earnings: EPS in line with expectations, revenues disappoint

Price target increased by 7.0% to AU$272

Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Cochlear (ASX:COH) Could Be Struggling To Allocate Capital

Upcoming dividend of AU$1.75 per share at 1.2% yield

Cochlear Limited Introduces Next Generation Cochlear Osia System with Ability to Have MRI at 3.0 T

Cochlear Limited to Report Fiscal Year 2024 Results on Aug 15, 2024

Full year 2023 earnings: EPS in line with analyst expectations despite revenue beat

Cochlear Limited Announces Andrew Denver, Non-Executive Director Intention to Retire At AGM to Be Held on 17 October 2023

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Upcoming dividend of AU$1.55 per share at 1.3% yield

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Cochlear Limited Provides Earnings Outlook for the Year 2023

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Is Cochlear (ASX:COH) A Risky Investment?

Cochlear Limited, Annual General Meeting, Oct 17, 2023

Is Cochlear Limited (ASX:COH) Worth AU$205 Based On Its Intrinsic Value?

FDA Approves Cochlear Limited's Nucleus 8 Sound Processor, Smaller, Smarter, Better Connected Cochlear Implant Technology

Key Executive recently bought AU$97k worth of stock

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Should Shareholders Reconsider Cochlear Limited's (ASX:COH) CEO Compensation Package?

Upcoming dividend of AU$1.45 per share

Cochlear's (ASX:COH) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why Cochlear (ASX:COH) Can Manage Its Debt Responsibly

Full year 2022 earnings: EPS misses analyst expectations

Cochlear Announces Final Dividend Payable on 17 October 2022

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Cochlear Limited Appoints Karen Penrose to Board, Effective on 1 July 2022

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

Cochlear Limited, Annual General Meeting, Oct 18, 2022

Cochlear Limited to Report First Half, 2023 Results on Feb 15, 2023

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal